Director/PDMR Shareholding

RNS Number : 6251S

GlaxoSmithKline PLC

25 September 2014

 



Notification of Transactions of

Directors and Persons Discharging Managerial Responsibility

Award under the GlaxoSmithKline Deferred Investment Award programme

In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 25 September 2014 of a change in the interests of the following Person Discharging Managerial Responsibility Person ('PDMR') in the Ordinary Shares of GSK as a result of awards made under the GlaxoSmithKline Deferred Investment Award programme (the 'Programme') on 24 September 2014.

Awards are made over notional Ordinary Shares.  Vesting is subject to the individual not having served GSK notice or having been terminated by GSK for cause. The awards will not accrue dividends, and on vesting, will be paid in cash.  Executive Directors are not eligible to receive awards under the Programme.  

Both awards relate to the PDMR's employment prior to his being appointed to GSK's Corporate Executive Committee.

PDMR	Number of notional Ordinary Shares subject to the award	Vesting date
N Hirons	17,489	26 August 2016
	14,940	12 February 2017

The closing middle market price of an Ordinary Share on 24 September 2014 was £14.285.

V A Whyte

Company Secretary

25 September 2014

 

END

 

 

RDSLELFLZKFBBBD